Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Virchow Biotech Private Limited
EIR
•Virchow Biotech Private Limited•November 7, 2014

Virchow Biotech Private Limited – FDA EIR, Nov 7, 2014

Record Details

An FDA Pre-Approval Inspection of VIRCHOW BIOTECH PVT LTD in Hyderabad, India, took place from November 3 to November 7, 2014. This inspection evaluated the facility's compliance with Current Good Manufacturing Practices (21 CFR 210/211) for drug manufacturing, particularly focusing on a drug product transfer. The inspection identified five significant issues, documented on an FDA-483 form. Main violations included the lack of a formal assessment for variable or nonlinear stability test results and insufficient system suitability requirements in HPLC assay methods, which did not mandate %RSD determination throughout chromatographic runs. A critical deviation concerning incomplete peak elution due to mobile phase evaporation was not followed by a Corrective Action Preventative Action (CAPA). Additionally, the firm lacked a written procedure for transferring analytical test methods from a collaborating site, and a specific stability testing method (QC-STP-190) failed to assess interference from other components. Management committed to immediate corrections, including revising stability protocols, updating HPLC procedures, implementing CAPA investigations, revalidating analytical methods, and performing additional method specificity assessments. A written response was promised within 15 days.

Company
Virchow Biotech Private Limited
Inspection date
November 7, 2014
Product type
drugs
Office
Office of Regulatory Affairs
People
  • G.V. Srinivas (company_representative)
  • Murali Tummuru (company_representative)
  • Azza Talaat
  • Hemanth Nandigala (recipient)
  • V.B. Sunder (company_representative)
View Company Profile

ID · 898b8c92-7e92-445e-8714-09a48879a40c

Violation Codes3
FD&C Act 501(a)(2)(B)21 CFR 21121 CFR 210

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Virchow Biotech Private Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.